Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT
NCT00007189Phase 3Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Jan 2001
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of naproxen, celecoxib in Alzheimer's disease (AD), sponsored by Seattle Institute for Biomedical and Clinical Research. Started Jan 2001; status: completed.
02
Drugs
naproxencelecoxib
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00007189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007189.